IFF to sell Pharma Solutions business to Roquette for US$ 2.85 billion
Pharma Solutions operates 10 research and development and/or production sites globally
Pharma Solutions operates 10 research and development and/or production sites globally
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Both organisations enter into a long- term collaboration to expand patient access in India
Mungara has over 25+ years of experience in the supply chain domain
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated